Healthy People Clinical Trial
— NEURORELAXOfficial title:
Longitudinal Study of the Effects of Neurofeedback Training on the Level of Relaxation in Healthy Population: Characterization at the Electrophysiological and Behavioral Levels
This longitudinal study deals with the characterization of the electrophysiological and behavioral effects of alpha-based neurofeedback training on the brain networks involved in the relaxation process of healthy people.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | September 15, 2021 |
Est. primary completion date | September 15, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Voluntary adult subjects, aged 18 to 60 - No known neurological history - Having an anxiety level higher than 35 on the STAI-YA scale - Insured under the French social security system - Signature of the informed consent - Absence of visual, hearing, sensory or motor deficits incompatible with participation in the study Exclusion Criteria: - recreational use of psychotropic drugs - ongoing anxiolytic / benzodiazepine treatment - current depressive episode and/or generalized anxiety troubles - person under guardianship, curatorship or safeguarding of justice or any other measure - administrative or judicial deprivation of rights or liberty - pregnant or breastfeeding - unable to give consent - person subject to a period of exclusion from further research |
Country | Name | City | State |
---|---|---|---|
France | Centre de Neuro-Imagerie de recherche (CENIR), ICM | Paris |
Lead Sponsor | Collaborator |
---|---|
Centre National de la Recherche Scientifique, France | Institut du Cerveau et de la Moelle Epinière, Institut National de la Santé Et de la Recherche Médicale, France, myBrain Technologies, Sorbonne University |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in alpha frequency band power at the end of the 12 neurofeedback training sessions relative to the initial, pre-training, alpha power level. | Individual EEG power measures in alpha band (between 7 and 13 Hz), performed over several minutes at rest, pre- and post-training, on every session. | From the 1st training session until the end of the 12th training session, the time frame of the assessment is 22 days minimum and 96 days maximum, with a minimum of 1 training session and a maximum of 3 training sessions per week. | |
Primary | Change in alpha frequency band power at post-training relative to pre-training across every training session. | Individual EEG power measures in alpha band (between 7 and 13 Hz), performed over several minutes at rest, pre- and post-training, on every session. | From the 1st training session until the end of the 12th training session, the time frame of the assessment is 22 days minimum and 96 days maximum, with a minimum of 1 training session and a maximum of 3 training sessions per week. | |
Secondary | Change in the EEG power spectrum at the end of the 12 neurofeedback training sessions relative to the initial, pre-training, EEG spectral content. | EEG signal measurement performed over several minutes at rest, pre- and post-training, on every session; EEG power spectrum analysis between 0.5 and 45 Hz. | From the 1st training session until the end of the 12th training session, the time frame of the assessment is 22 days minimum and 96 days maximum, with a minimum of 1 training session and a maximum of 3 training sessions per week. | |
Secondary | Change in the EEG power spectrum at post-training relative to pre-training across every training session. | EEG signal measurement performed over several minutes at rest, pre- and post-training, on every session; EEG power spectrum analysis between 0.5 and 45 Hz. | From the 1st training session until the end of the 12th training session, the time frame of the assessment is 22 days minimum and 96 days maximum, with a minimum of 1 training session and a maximum of 3 training sessions per week. | |
Secondary | Change in anxiety trait after the 12 neurofeedback training sessions relative to before the first training session. | Anxiety trait level measured by the State-Trait Anxiety Inventory (Trait evaluation, STAI-YA), before the 1st neurofeedback training session and after the last neurofeedback training session. | Assessments are performed before the 1st training session (at day 1) and after the 12th training session (at day 22 up to 96, depending on the number of training sessions per week (1 minimum, 3 maximum)). | |
Secondary | Change in affective state after the 12 neurofeedback training sessions relative to before the first training session. | Affective state measured by the Positive and Negative Affect Schedule (PANAS), before the 1st neurofeedback training session and after the last neurofeedback training session. | Assessments are performed before the 1st training session (at day 1) and after the 12th training session (at day 22 up to 96, depending on the number of training sessions per week (1 minimum, 3 maximum)). | |
Secondary | Change in stress level after the 12 neurofeedback training sessions relative to before the first training session. | Subjective stress level measured by the Perceived Stress Scale (PSS), before the 1st neurofeedback training session and after the last neurofeedback training session. | Assessments are performed before the 1st training session (at day 1) and after the 12th training session (at day 22 up to 96, depending on the number of training sessions per week (1 minimum, 3 maximum)). | |
Secondary | Changes in anxiety state at post-training relative to pre-training across every training session. | Anxiety state level measured by the State-Trait Anxiety Inventory (State evaluation, STAI-YB) before and after every training session. | Assessments are performed before and after every training session; the estimated period of time of assessment is 22 days minimum and 96 days maximum, with a minimum of 1 training session and a maximum of 3 training sessions per week. | |
Secondary | Change in relaxation state at post-training relative to pre-training across every training session. | Subjective relaxation state measured by a visual analog scale before and after every training session. | Assessments are performed before and after every training session; the estimated period of time of assessment is 22 days minimum and 96 days maximum, with a minimum of 1 training session and a maximum of 3 training sessions per week. | |
Secondary | Correlation between the changes in electrophysiological measurements and the changes in behavioral measures. | Correlation between EEG power spectrum features and scores at behavioral questionnaires and scales, across training sessions. | From the 1st training session until the 12th training session (minimum of 22 days and maximum of 96 days, with a minimum of 1 training session and a maximum of 3 training sessions per week). | |
Secondary | Changes in EEG power spectrum during the training sessions from the 1st until the 12th sessions. | EEG signal measured continuously during the 21 minutes of neurofeedback training, on every session; EEG power spectrum analysis between 0.5 and 45 Hz. | From the 1st training session until the 12th training session (minimum of 22 days and maximum of 96 days, with a minimum of 1 training session and a maximum of 3 training sessions per week). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05410795 -
Establishment and Verification of Pancreatic Volume Formula Based on Imaging
|
||
Not yet recruiting |
NCT00966784 -
The Effect of 2 Months Daily Supplementation of Orange Juice With Fibers
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT00966862 -
The Glycemic Effect of Taking a Supplementation of Orange Juice With Fibers
|
Phase 1/Phase 2 | |
Recruiting |
NCT04213105 -
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
|
Phase 1 | |
Completed |
NCT01840982 -
The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male
|
N/A | |
Not yet recruiting |
NCT05619393 -
Comparison of Kinematic Movements Between ACL Deficiency With ACL Reconstruction and Healthy People
|
N/A | |
Recruiting |
NCT05095753 -
Data Collection of Heart Rate and Blood Pressure
|
||
Enrolling by invitation |
NCT05140577 -
Reliability and Validity of the Evaluation of Hip Abductors Strength (RAVEHABDS)
|
||
Completed |
NCT05888246 -
Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram
|
N/A | |
Not yet recruiting |
NCT04319211 -
Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress
|
||
Recruiting |
NCT01261195 -
Establishment of Vascular Permeability Model for Research Purpose by Human Umbilical Vascular Endothelial Cells
|
N/A | |
Not yet recruiting |
NCT01079585 -
The Effect of 40gr Okara on Gastric Emptying
|
N/A | |
Completed |
NCT01476865 -
Articular Sonography: Healthy Subjects Versus Rheumatoid Arthritis Patients
|
N/A | |
Not yet recruiting |
NCT01075568 -
The Satiety Effect After Okara Compared to Porridge Eating
|
N/A | |
Completed |
NCT04389255 -
Developing a Balance Assessment System
|
||
Not yet recruiting |
NCT06303635 -
Safety of UFRJvac, Trivalent COVID-19 Vaccine
|
||
Recruiting |
NCT03293056 -
HIIH Versus HMC: Randomized Clinical Trial
|
N/A | |
Not yet recruiting |
NCT06186635 -
Comparison of Traditional and Artificial Intelligence-Assisted Yoga
|
N/A | |
Not yet recruiting |
NCT06006182 -
The Effects of Freeze-Dried Whole Grape Powder on Chronic Disease and Cardiovascular Risk Factors-a Pilot Study
|
N/A | |
Completed |
NCT03651947 -
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults
|
Phase 1 |